The age again in the eye of the COVID-19 storm: evidence-based decision making.


Por: Martín MC, Jurado A, Abad-Molina C, Orduña A, Yarce O, Navas AM, Cunill V, Escobar D, Boix F, Burillo-Sanz S, Vegas-Sánchez MC, Jiménez-de Las Pozas Y, Melero J, Aguilar M, Sobieschi OI, López-Hoyos M, Ocejo-Vinyals G, San Segundo D, Almeida D, Medina S, Fernández L, Vergara E, Quirant B, Martínez-Cáceres E, Boiges M, Alonso M, Esparcia-Pinedo L, López-Sanz C, Muñoz-Vico J, López-Palmero S, Trujillo A, Álvarez P, Prada Á, Monzón D, Ontañón J, Marco FM, Mora S, Rojo R, González-Martínez G, Martínez-Saavedra MT, Gil-Herrera J, Cantenys-Molina S, Hernández M, Perurena-Prieto J, Rodríguez-Bayona B, Martínez A, Ocaña E and Molina J

Publicada: 20 may 2021 Ahead of Print: 20 may 2021
Resumen:
BACKGROUND: One hundred fifty million contagions, more than 3 million deaths and little more than 1 year of COVID-19 have changed our lives and our health management systems forever. Ageing is known to be one of the significant determinants for COVID-19 severity. Two main reasons underlie this: immunosenescence and age correlation with main COVID-19 comorbidities such as hypertension or dyslipidaemia. This study has two aims. The first is to obtain cut-off points for laboratory parameters that can help us in clinical decision-making. The second one is to analyse the effect of pandemic lockdown on epidemiological, clinical, and laboratory parameters concerning the severity of the COVID-19. For these purposes, 257 of SARSCoV2 inpatients during pandemic confinement were included in this study. Moreover, 584 case records from a previously analysed series, were compared with the present study data. RESULTS: Concerning the characteristics of lockdown series, mild cases accounted for 14.4, 54.1% were moderate and 31.5%, severe. There were 32.5% of home contagions, 26.3% community transmissions, 22.5% nursing home contagions, and 8.8% corresponding to frontline worker contagions regarding epidemiological features. Age > 60 and male sex are hereby confirmed as severity determinants. Equally, higher severity was significantly associated with higher IL6, CRP, ferritin, LDH, and leukocyte counts, and a lower percentage of lymphocyte, CD4 and CD8 count. Comparing this cohort with a previous 584-cases series, mild cases were less than those analysed in the first moment of the pandemic and dyslipidaemia became more frequent than before. IL-6, CRP and LDH values above 69 pg/mL, 97 mg/L and 328 U/L respectively, as well as a CD4 T-cell count below 535 cells/µL, were the best cut-offs predicting severity since these parameters offered reliable areas under the curve. CONCLUSION: Age and sex together with selected laboratory parameters on admission can help us predict COVID-19 severity and, therefore, make clinical and resource management decisions. Demographic features associated with lockdown might affect the homogeneity of the data and the robustness of the results.

Filiaciones:
Martín MC:
 Centro de Hemoterapia y Hemodonación de Castilla y León, Valladolid, Spain

Jurado A:
 Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain.

Abad-Molina C:
 Department of Microbiology and Immunology, Hospital Clínico Universitario, Valladolid, Spain

Orduña A:
 Department of Microbiology and Immunology, Hospital Clínico Universitario, Valladolid, Spain

Yarce O:
 Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain

Navas AM:
 Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain

Cunill V:
 Department of Immunology, Hospital Universitario Son Espases-Human Immunopathology Research Laboratory, Institut d'Investigació Sanitària de les Illes Balears (IdISBa), Palma de Mallorca, Spain

Escobar D:
 Department of Immunology, Hospital Universitario Son Espases-Human Immunopathology Research Laboratory, Institut d'Investigació Sanitària de les Illes Balears (IdISBa), Palma de Mallorca, Spain

Boix F:
 Department of Immunology, Hospital Clínico Universitario, Salamanca, Spain

Burillo-Sanz S:
 Department of Immunology, Hospital Clínico Universitario, Salamanca, Spain

Vegas-Sánchez MC:
 Department of Immunology, Fundación Jiménez Díaz, Madrid, Spain

Jiménez-de Las Pozas Y:
 Department of Immunology, Fundación Jiménez Díaz, Madrid, Spain

Melero J:
 Department of Immunology, Hospital Universitario de Badajoz, Badajoz, Spain

Aguilar M:
 Department of Immunology, Hospital Universitario de Badajoz, Badajoz, Spain

Sobieschi OI:
 Department of Immunology, Hospital Universitario de Badajoz, Badajoz, Spain

López-Hoyos M:
 Department of Immunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain

Ocejo-Vinyals G:
 Department of Immunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain

San Segundo D:
 Department of Immunology, Hospital Universitario Marqués de Valdecilla, Santander, Spain

Almeida D:
 Laboratory of Immunology, Complejo Hospitalario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain

Medina S:
 Laboratory of Immunology, Complejo Hospitalario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain

Fernández L:
 Laboratoy of Immunology and Genetics, Hospital San Pedro de Alcántara, Cáceres, Spain

Vergara E:
 Laboratoy of Immunology and Genetics, Hospital San Pedro de Alcántara, Cáceres, Spain

Quirant B:
 Department of Immunology, Hospital Germans Trias i Pujols, Barcelona, Spain

Martínez-Cáceres E:
 Department of Immunology, Hospital Germans Trias i Pujols, Barcelona, Spain

Boiges M:
 Department of Immunology, Hospital Germans Trias i Pujols, Barcelona, Spain

Alonso M:
 Department of Immunology, Hospital de Cruces, Baracaldo, Spain

Esparcia-Pinedo L:
 Department of Immunology, Hospital Universitario La Princesa, Madrid, Spain

López-Sanz C:
 Department of Immunology, Hospital Universitario La Princesa, Madrid, Spain

Muñoz-Vico J:
 Department of Immunology, Hospital Torrecárdenas, Almería, Spain

López-Palmero S:
 Department of Immunology, Hospital Torrecárdenas, Almería, Spain

Trujillo A:
 Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain

Álvarez P:
 Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain

Prada Á:
 Department of Immunology, Hospital de Donostia, San Sebastián, Spain

Monzón D:
 Department of Immunology, Hospital de Donostia, San Sebastián, Spain

Ontañón J:
 Unit of Immunology, Hospital General Universitario, Albacete, Spain

:
 Laboratory Unit, Hospital General, Alicante, Spain

Mora S:
 Laboratory Unit, Hospital General, Alicante, Spain

Rojo R:
 Department of Immunology, Complejo Hospitalario, La Coruña, Spain

González-Martínez G:
 Unit of Immunology, Hospital Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain

Martínez-Saavedra MT:
 Unit of Immunology, Hospital Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain

Gil-Herrera J:
 Department of Immunology, Hospital General Universitario e Instituto de Investigación Sanitaria, "Gregorio Marañón", Madrid, Spain

Cantenys-Molina S:
 Department of Immunology, Hospital General Universitario e Instituto de Investigación Sanitaria, "Gregorio Marañón", Madrid, Spain

Hernández M:
 Department of Immunology, Hospital Universitario Vall d'Hebron, Barcelona, Spain

Perurena-Prieto J:
 Department of Immunology, Hospital Universitario Vall d'Hebron, Barcelona, Spain

Rodríguez-Bayona B:
 Laboratory Unit, Hospital Juan Ramón Jiménez, Huelva, Spain

Martínez A:
 Laboratory Unit, Complejo Hospitalario, Jaén, Spain

Ocaña E:
 Laboratory Unit, Complejo Hospitalario, Jaén, Spain

Molina J:
 Department of Immunology and Allergology, Hospital Universitario Reina Sofía-Instituto de Investigación Biomédica de Córdoba (IMIBIC), Avd. Menéndez Pidal s/n, 14004, Córdoba, Spain
ISSN: 17424933





IMMUNITY & AGEING
Editorial
BioMed Central, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 18 Número: 1
Páginas: 24-24
WOS Id: 000652608400001
ID de PubMed: 34016150
imagen Open Access

FULL TEXT

imagen Published Version
No Accesible

MÉTRICAS